Chemical compounds

Compounds of the formula (1) : or pharmaceutically acceptable salts thereof as described, wherein is a pyridine, pyrazine or triazine ring; R is C1-6alkyl, C2-6alkenyl, C3-5cycloalkylC1-6alkyl, or C1-6alkyl substituted by 1 to 6 fluoro groups; R is C1-6alkylthio, C1-6alkylsulphonyl, C1-6alkoxy, hydr...

Full description

Saved in:
Bibliographic Details
Main Authors FLYNN; SEAN T, COATES; WILLIAM J, RAWLINGS; DEREK A
Format Patent
LanguageEnglish
Published 10.09.1991
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of the formula (1) : or pharmaceutically acceptable salts thereof as described, wherein is a pyridine, pyrazine or triazine ring; R is C1-6alkyl, C2-6alkenyl, C3-5cycloalkylC1-6alkyl, or C1-6alkyl substituted by 1 to 6 fluoro groups; R is C1-6alkylthio, C1-6alkylsulphonyl, C1-6alkoxy, hydroxy, hydrogen, hydrazino, C1-6alkyl, phenyl, -NHCOR wherein R is hydrogen or C1-6alkyl, or -NR R , wherein R and R together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino, hexahydroazepino, morpholino or piperazino ring, or R and R are independently hydrogen, C3-5cycloalkyl or C1-6alkyl which is optionally substituted by -CF3, phenyl, -S(O)nC1-6alkyl wherein n is 0, 1 or 2, -OR , -CO2R or -NR R wherein R to R are independently hydrogen or C1-6alkyl, provided that the carbon atom adjacent to the nitrogen atom is not substituted by said -S(O)nC1-6alkyl, -OR or -NR R groups; and when is a pyrazine ring it may be further substituted by hydroxy when R is hydroxy. Their use as medicaments, pharmaceutical compositions comprising them and processes for their preparation are also described.
Bibliography:Application Number: US19890365469